Strata Critical Medical Inc (SRTA)

Currency in USD
4.300
+0.070(+1.65%)
Closed·
4.3000.000(0.00%)
·
SRTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.2504.340
52 wk Range
2.3506.020
Key Statistics
Prev. Close
4.23
Open
4.27
Day's Range
4.25-4.34
52 wk Range
2.35-6.02
Volume
731.65K
Average Volume (3m)
884.97K
1-Year Change
8.59%
Book Value / Share
3.32
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SRTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.250
Upside
+161.63%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Strata Critical Medical Inc Company Profile

Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Employees
310

Strata Critical Medical Inc Earnings Call Summary for Q1/2025

  • Blade Air Mobility reported first profitable Q1 adjusted EBITDA, with 11% YoY revenue growth excluding Canadian operations
  • Passenger segment revenue increased 42% YoY; company ended Q1 with $120M cash, no debt
  • Stock surged 10.96% in premarket trading after earnings; full-year revenue and adjusted EBITDA guidance reiterated
  • Company preparing for eVTOL integration, with expected deployments in late 2025/early 2026
  • CEO expressed optimism about growth potential with eVTOL deployment; focus on strategic M&A and fleet expansion
Last Updated: 12/05/2025, 13:58
Read Full Transcript

Compare SRTA to Peers and Sector

Metrics to compare
SRTA
Peers
Sector
Relationship
P/E Ratio
−11.2x−4.5x−0.6x
PEG Ratio
−0.060.070.00
Price/Book
1.3x1.7x2.6x
Price / LTM Sales
1.4x0.6x3.3x
Upside (Analyst Target)
161.6%19.3%40.3%
Fair Value Upside
Unlock−1.9%3.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.250
(+161.63% Upside)

Earnings

Latest Release
Nov 10, 2025
EPS / Forecast
-0.12 / 0.02
Revenue / Forecast
49.29M / 61.31M
EPS Revisions
Last 90 days

SRTA Income Statement

People Also Watch

154.22
ALAB
+6.52%
8.240
ONDS
-2.37%
48.450
IREN
+2.06%
9.29
LUNR
-1.06%

FAQ

What Stock Exchange Does Strata Critical Medical Trade On?

Strata Critical Medical is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Strata Critical Medical?

The stock symbol for Strata Critical Medical is "SRTA."

What Is the Strata Critical Medical Market Cap?

As of today, Strata Critical Medical market cap is 371.38M.

What Is Strata Critical Medical's Earnings Per Share (TTM)?

The Strata Critical Medical EPS (TTM) is -0.41.

When Is the Next Strata Critical Medical Earnings Date?

Strata Critical Medical will release its next earnings report on 16 Mar 2026.

From a Technical Analysis Perspective, Is SRTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Strata Critical Medical Stock Split?

Strata Critical Medical has split 0 times.

How Many Employees Does Strata Critical Medical Have?

Strata Critical Medical has 310 employees.

What is the current trading status of Strata Critical Medical (SRTA)?

As of 27 Nov 2025, Strata Critical Medical (SRTA) is trading at a price of 4.300, with a previous close of 4.230. The stock has fluctuated within a day range of 4.250 to 4.340, while its 52-week range spans from 2.350 to 6.020.

What Is Strata Critical Medical (SRTA) Price Target According to Analysts?

The average 12-month price target for Strata Critical Medical is USD11.25, with a high estimate of USD11.25 and a low estimate of USD11.25. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +161.63% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.